Bliss GVS Pharma Limited (NSE:BLISSGVS)
India flag India · Delayed Price · Currency is INR
116.42
-2.19 (-1.85%)
Mar 12, 2025, 3:29 PM IST

Bliss GVS Pharma Statistics

Total Valuation

NSE:BLISSGVS has a market cap or net worth of INR 12.45 billion. The enterprise value is 11.58 billion.

Market Cap 12.45B
Enterprise Value 11.58B

Important Dates

The next estimated earnings date is Wednesday, April 30, 2025.

Earnings Date Apr 30, 2025
Ex-Dividend Date Jul 18, 2024

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) +0.07%
Shares Change (QoQ) -1.02%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 40.49M

Valuation Ratios

The trailing PE ratio is 20.89.

PE Ratio 20.89
Forward PE n/a
PS Ratio n/a
PB Ratio n/a
P/TBV Ratio 1.24
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 19.42
EV / Sales 1.43
EV / EBITDA 8.47
EV / EBIT 10.95
EV / FCF n/a

Financial Position

Current Ratio n/a
Quick Ratio n/a
Debt / Equity 0.09
Debt / EBITDA 0.69
Debt / FCF n/a
Interest Coverage 14.22

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) 5.99%
Return on Capital Employed (ROCE) n/a
Revenue Per Employee 9.75M
Profits Per Employee 717,359
Employee Count 831
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +1.87% in the last 52 weeks. The beta is 0.90, so NSE:BLISSGVS's price volatility has been similar to the market average.

Beta (5Y) 0.90
52-Week Price Change +1.87%
50-Day Moving Average 146.99
200-Day Moving Average 131.70
Relative Strength Index (RSI) 35.01
Average Volume (20 Days) 571,041

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, NSE:BLISSGVS had revenue of INR 8.10 billion and earned 596.13 million in profits. Earnings per share was 5.62.

Revenue 8.10B
Gross Profit 3.82B
Operating Income 1.06B
Pretax Income 982.50M
Net Income 596.13M
EBITDA 1.34B
EBIT 1.06B
Earnings Per Share (EPS) 5.62
Full Income Statement

Balance Sheet

The company has 2.20 billion in cash and 941.72 million in debt, giving a net cash position of 1.26 billion.

Cash & Cash Equivalents 2.20B
Total Debt 941.72M
Net Cash 1.26B
Net Cash Per Share n/a
Equity (Book Value) 10.48B
Book Value Per Share 96.16
Working Capital n/a
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 47.11%, with operating and profit margins of 13.05% and 7.36%.

Gross Margin 47.11%
Operating Margin 13.05%
Pretax Margin 12.13%
Profit Margin 7.36%
EBITDA Margin 16.56%
EBIT Margin 13.05%
FCF Margin n/a

Dividends & Yields

This stock pays an annual dividend of 0.50, which amounts to a dividend yield of 0.40%.

Dividend Per Share 0.50
Dividend Yield 0.40%
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -0.07%
Shareholder Yield 0.33%
Earnings Yield 4.79%
FCF Yield n/a
Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score n/a